Literature DB >> 11717270

Novel posttranslational activation of the LYS2-encoded alpha-aminoadipate reductase for biosynthesis of lysine and site-directed mutational analysis of conserved amino acid residues in the activation domain of Candida albicans.

S Guo1, S A Evans, M B Wilkes, J K Bhattacharjee.   

Abstract

The alpha-aminoadipate pathway for lysine biosynthesis is present only in fungi. The alpha-aminoadipate reductase (AAR) of this pathway catalyzes the conversion of alpha-aminoadipic acid to alpha-aminoadipic-delta-semialdehyde by a complex mechanism involving two gene products, Lys2p and Lys5p. The LYS2 and LYS5 genes encode, respectively, a 155-kDa inactive AAR and a 30-kDa phosphopantetheinyl transferase (PPTase) which transfers a phosphopantetheinyl group from coenzyme A (CoA) to Lys2p for the activation of Lys2p and AAR activity. In the present investigation, we have confirmed the posttranslational activation of the 150-kDa Lys2p of Candida albicans, a pathogenic yeast, in the presence of CoA and C. albicans lys2 mutant (CLD2) extract as a source of PPTase (Lys5p). The recombinant Lys2p or CLD2 mutant extract exhibited no AAR activity with or without CoA. However, the recombinant 150-kDa Lys2p, when incubated with CLD2 extract and CoA, exhibited significant AAR activity compared to that of wild-type C. albicans CAI4 extract. The PPTase in the CLD2 extract was required only for the activation of Lys2p and not for AAR reaction. Site-directed mutational analysis of G882 and S884 of the Lys2p activation domain (LGGHSI) revealed no AAR activity, indicating that these two amino acids are essential for the activation. Replacement of other amino acid residues in the domain resulted in partial or full AAR activity. These results demonstrate the posttranslational activation and the requirement of specific amino acid residues in the activation domain of the AAR of C. albicans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717270      PMCID: PMC95560          DOI: 10.1128/JB.183.24.7120-7125.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

1.  Studies in lysine biosynthesis. IV. Mechanism of activation and reduction of alpha-aminoadipic acid.

Authors:  S SAGISAKA; K SHIMURA
Journal:  J Biochem       Date:  1962-09       Impact factor: 3.387

2.  Characterization of a double gene disruption in the LYS2 locus of the pathogenic yeast, Candida albicans.

Authors:  V Bhattacherjee; J K Bhattacharjee
Journal:  Med Mycol       Date:  1999-12       Impact factor: 4.076

3.  Lysine inhibition of in vivo homocitrate synthesis in Penicillium chrysogenum.

Authors:  A L Demain; P S Masurekar
Journal:  J Gen Microbiol       Date:  1974-05

4.  Relationship among the genes, enzymes, and intermediates of the biosynthetic pathway of lysine in Saccharomyces.

Authors:  J K Bhattacharjee; A K Sinha
Journal:  Mol Gen Genet       Date:  1972

5.  Control of a lysine-biosynthetic step by two unlinked genes of Saccharomyces.

Authors:  A K Sinha; J K Bhattacharjee
Journal:  Biochem Biophys Res Commun       Date:  1970       Impact factor: 3.575

6.  Accumulation of tricarboxylic acids related to lysine biosynthesis in a yeast mutant.

Authors:  J K Bhattacharjee; M Strassman
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

7.  Characterization of the lys2 gene of Acremonium chrysogenum encoding a functional alpha-aminoadipate activating and reducing enzyme.

Authors:  M J Hijarrubia; J F Aparicio; J Casqueiro; J F Martín
Journal:  Mol Gen Genet       Date:  2001-02

8.  Functional and evolutionary relationship between arginine biosynthesis and prokaryotic lysine biosynthesis through alpha-aminoadipate.

Authors:  J Miyazaki; N Kobashi; M Nishiyama; H Yamane
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

9.  Lysine biosynthesis in Saccharomyces. Conversion of -aminoadipate into -aminoadipic -semialdehyde.

Authors:  A K Sinha; J K Bhattacharjee
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

Review 10.  alpha-Aminoadipate pathway for the biosynthesis of lysine in lower eukaryotes.

Authors:  J K Bhattacharjee
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

View more
  8 in total

Review 1.  The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life.

Authors:  Joris Beld; Eva C Sonnenschein; Christopher R Vickery; Joseph P Noel; Michael D Burkart
Journal:  Nat Prod Rep       Date:  2014-01       Impact factor: 13.423

2.  Functional and phylogenetic divergence of fungal adenylate-forming reductases.

Authors:  Daniel Kalb; Gerald Lackner; Dirk Hoffmeister
Journal:  Appl Environ Microbiol       Date:  2014-08-01       Impact factor: 4.792

3.  Site-directed mutational analysis of the novel catalytic domains of alpha-aminoadipate reductase (Lys2p) from Candida albicans.

Authors:  S Guo; J K Bhattacharjee
Journal:  Mol Genet Genomics       Date:  2003-03-22       Impact factor: 3.291

Review 4.  FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism.

Authors:  Sergey A Krupenko
Journal:  Chem Biol Interact       Date:  2008-09-19       Impact factor: 5.192

Review 5.  Regulation and compartmentalization of β-lactam biosynthesis.

Authors:  Juan F Martín; Ricardo V Ullán; Carlos García-Estrada
Journal:  Microb Biotechnol       Date:  2009-05-31       Impact factor: 5.813

6.  Reconfiguration of Transcriptional Control of Lysine Biosynthesis in Candida albicans Involves a Central Role for the Gcn4 Transcriptional Activator.

Authors:  Yumnam Priyadarshini; Krishnamurthy Natarajan
Journal:  mSphere       Date:  2016-01-22       Impact factor: 4.389

7.  Molecular evolution of adenylating domain of aminoadipate reductase.

Authors:  Kwang-Deuk An; Hiromi Nishida; Yoshiharu Miura; Akira Yokota
Journal:  BMC Evol Biol       Date:  2003-05-08       Impact factor: 3.260

8.  Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target.

Authors:  Katharine S Dobb; Sarah J Kaye; Nicola Beckmann; John L Thain; Lubomira Stateva; Mike Birch; Jason D Oliver
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.